134 related articles for article (PubMed ID: 4120944)
1. The treatment of leprosy and its acute complications.
Jopling WH
Trop Doct; 1973 Jan; 3(1):8-11. PubMed ID: 4120944
[No Abstract] [Full Text] [Related]
2. Antileprosy drugs.
Br Med J; 1971 Jul; 3(5767):174-6. PubMed ID: 4104273
[No Abstract] [Full Text] [Related]
3. Comments on the chemotherapy of leprosy as influenced by present knowledge of Mycobacterium leprae.
Pattyn SR
Lepr Rev; 1973 Sep; 43(3):126-36. PubMed ID: 4120832
[No Abstract] [Full Text] [Related]
4. Chemotherapy of leprosy.
Leiker DL
Int J Lepr Other Mycobact Dis; 1971; 39(2):462-6. PubMed ID: 4948084
[No Abstract] [Full Text] [Related]
5. Efficacy of clofazimine in the prophylaxis and suppression of reactive phases of lepromatous leprosy.
Karat AB; Jeevaratnam A; Karat S; Rao PS
Int J Lepr Other Mycobact Dis; 1971; 39(4):838-41. PubMed ID: 5170472
[No Abstract] [Full Text] [Related]
6. The evaluation of present antileprosy compounds.
Browne SG
Adv Pharmacol (1962); 1969; 7():211-51. PubMed ID: 4190238
[No Abstract] [Full Text] [Related]
7. Clofazimine (B663, Geigy) in leprosy reactions.
Smith RB
Australas J Dermatol; 1972 Apr; 13(1):31-5. PubMed ID: 5082494
[No Abstract] [Full Text] [Related]
8. Correlation of laboratory and clinical data during treatment of leprosy.
Pattyn SR; Rollier R; Rollier MR; De Muynck A; Janssens PG; Verdoolaeghe-Van Loo G
Ann Soc Belg Med Trop; 1972; 52(6):537-48. PubMed ID: 4574223
[No Abstract] [Full Text] [Related]
9. [On the chemoresistance of the Hansen bacillus and the treatment of leprosy with drug associations].
Floch HA
Bull Soc Pathol Exot Filiales; 1966; 59(2):188-92. PubMed ID: 6012833
[No Abstract] [Full Text] [Related]
10. Controlled drug trial of B.663 compared with DDS. Preliminary (48 week) report.
Tolentino JG; Rodriquez JN; Abalos RM
Int J Lepr Other Mycobact Dis; 1971; 39(3):738-41. PubMed ID: 5169924
[No Abstract] [Full Text] [Related]
11. Therapy of leprosy.
Convit J; Browne SG; Languillon J; Pettit JH; Ramanujam K; Sagher F; Sheskin J; Tarabini G; de Souza Lima L; Tolentino JG; Waters MF; Bechelli LM; MartÃnez DomÃnguez V
Bull World Health Organ; 1970; 42(5):667-72. PubMed ID: 5311056
[TBL] [Abstract][Full Text] [Related]
12. Management of neuritis in leprosy.
Pfaltzgraff RE
Trop Doct; 1973 Jul; 3(3):138-9. PubMed ID: 4715065
[No Abstract] [Full Text] [Related]
13. Experimental chemotherapy in leprosy, then and now.
Shepard CC
Int J Lepr Other Mycobact Dis; 1973; 41(3):307-19. PubMed ID: 4136732
[No Abstract] [Full Text] [Related]
14. The evaluation of present antileprosy compounds.
Browne SG
Adv Pharmacol Chemother; 1969; 7():211-51. PubMed ID: 4910168
[No Abstract] [Full Text] [Related]
15. The drug treatment of leprosy.
Browne SG
Practitioner; 1975 Oct; 215(1288):493-500. PubMed ID: 1202470
[No Abstract] [Full Text] [Related]
16. A survey of the drugs with activity against M. leprae in mice.
Shepard CC
Int J Lepr Other Mycobact Dis; 1971; 39(2):340-8. PubMed ID: 4948080
[No Abstract] [Full Text] [Related]
17. Drugs for leprosy.
Rees RJ
Trop Doct; 1973 Apr; 3(2):92-5. PubMed ID: 4691437
[No Abstract] [Full Text] [Related]
18. Growing points in leprosy research. 4. Recent advances in the chemotherapy of leprosy.
Ellard GA
Lepr Rev; 1974 Mar; 45(1):31-40. PubMed ID: 4136027
[No Abstract] [Full Text] [Related]
19. Studies on sulfone resistance in leprosy. 3. A case of "partial" resistance.
Pearson JM; Pettit JH; Rees RJ
Int J Lepr Other Mycobact Dis; 1968; 36(2):171-8. PubMed ID: 4877115
[No Abstract] [Full Text] [Related]
20. [Lampren in the treatment of leprosy].
Ahrens T
Schweiz Rundsch Med Prax; 1970 Mar; 59(11):387-9. PubMed ID: 5519711
[No Abstract] [Full Text] [Related]
[Next] [New Search]
